Collaborating in more than 150 countries.By clicking on a link below, you may enter a different part of this website, or a website outside of Janssen.com.These sections or websites are governed by their own Legal and Privacy Policies.
Asia Pacific (Regional)
English | Français | Nederlands
Deutsch | Français
Latin America (Regional)
Central America and the Caribbean
Spanish | English
English | Français
Welcome to Janssen Europe, Middle-East and Africa
VISIT JANSSEN GLOBAL
In 2014, UNAIDS announced its intention to end the AIDS epidemic by 2030. 1 Now, 6 years later, significant progress...
*/ Many things have changed this year, but not our flagship Corporate Social Responsibility (CSR) event, Cycling for...
Allitia Di Bernardo, EMEA Therapeutic Area Lead, CNS, IDV, and PAH, at Janssen Since stepping into my role as EMEA...
*/ In response to COVID-19 pandemic Johnson & Johnson have formed a new partnership with The World Continuing...
*/ There are up to 70 million people in Europe living with IMIDs such as psoriasis, rheumatoid arthritis, Crohn’s...
In our role as a global health leader, Johnson & Johnson is closely monitoring the COVID-19 pandemic, caused by the...
Our supply chain during COVID-19 Our supply chain teams around the world are working hard and diligently to meet...
*/ Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the...
Global support: Johnson & Johnson Announces a $50 Million Commitment to Support Frontline Health Workers Battling...
We're delighted to welcome six more data partners to join the HONEUR collaborative network of he Janssen Pharmaceutical...
This World AIDS Day, take time to recognise the power of human touch, through 5B : Proudly commissioned by Johnson...